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Department of Psychiatry, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada

Study Objectives: Posttraumatic stress disorder (PTSD) is associated with suicidal ideation (SI) and obstructive sleep apnea (OSA). There are no studies of
OSA diagnosed by sleep study and SI in patients with PTSD.
Methods: Forty consenting civilians with PTSD (38 female, mean ± standard deviation age: 44.60 ± 12.73) underwent a Level 3 home sleep apnea test
(WatchPAT200; Itamar Medical, Israel). OSA severity was measured with the respiratory disturbance index (RDI) (number of apneas, hypopneas and
respiratory effort related arousals per hour). SI was measured with Items 9, 35, 39, and 50 of the Brief Symptom Inventory (BSI). Other patient-rated
measures included the Beck Depression Inventory, second edition (BDI-II), PTSD Checklist for DSM-5 (PCL-5), and the Pittsburgh Sleep Quality Index PTSD
Addendum modified to include only Items 1c, 1e, 1f, and 1g that address nightmares.
Results: The RDI (r = .757, P < .001) and oxygen desaturation index (r = .633, P < .001) were directly correlated to SI. Multiple regression analysis using SI as
the dependent variable and patient-rated measures as independent variables revealed only RDI (β = .480, t = 4.167, P < .001) and BDI-II (β = .469, t = 3.375,
P = .002) as predictors of SI, with adjusted R 2 = 0.718. In patients with RDI < 30 events/h (n = 37) correlation of SI with RDI (r = .511, P = .001) but not ODI
(r = .312, P = .060) remained significant. Multiple regression analysis (when RDI < 30 events/h) revealed only BDI-II (β = .603, t = 3.492, P = .002), and not
RDI (β = .247, t = 1.723, P = .096) as a significant predictor of SI.
Conclusions: OSA severity in PTSD was directly related to SI. Depression was a significant mediator in the relationship between RDI and SI, with
OSA-related intermittent hypoxemia possibly contributing to this relationship only in severe OSA.
Keywords: autonomic nervous system, hypoxia, OSA, oxidative stress, PTSD, posttraumatic stress disorder, psychological trauma, sleep apnea, suicidal
ideation, suicide
Citation: Gupta MA, Jarosz P. Obstructive sleep apnea severity is directly related to suicidal ideation in posttraumatic stress disorder. J Clin Sleep Med.
2018;14(3):427–435.

BRIEF SUMMARY

Current Knowledge/Study Rationale: Posttraumatic stress disorder (PTSD) is associated with suicidal ideation (SI) and a high prevalence of OSA.
There are no studies that have examined the relationship of OSA diagnosed by sleep study and SI in patients with PTSD.
Study Impact: This study of 40 civilian patients with PTSD and OSA diagnosed by a home sleep apnea test presents the previously unreported finding
of a direct relationship between OSA severity (measured by the respiratory disturbance index) and SI. Depression was a significant mediator in the
relationship between OSA and SI across the entire range of OSA severity, with OSA-related intermittent hypoxemia possibly further contributing to the
association between OSA and SI only when patients with PTSD and severe OSA were considered.

suicidal ideation (SI) in general5,6 and involving patients with
PTSD.7 Systematic reviews of the literature on the relation between sleep disturbances and suicidal behaviors8–10 in general
have revealed mixed results, with insomnia and nightmares
emerging as independent risk factors for suicidal behaviors
in some studies, after controlling for psychiatric comorbidity
such as depression; there were no studies of OSA diagnosed
using sleep studies in these reviews.8–10 A 10-year longitudinal case-control study11 from a population-based community
sample of older adults indicated that complaints of difficulty
falling asleep and nonrestorative sleep at baseline were associated with an elevated risk for suicide at 10-year follow-up, after
controlling for depressive symptoms (odds ratio [OR] = 1.30,
95% confidence interval [CI] 1.04–1.63, P < .05). This study11
did not measure OSA.

I N T RO D U C T I O N
Patients with trauma exposure and posttraumatic stress disorder (PTSD) may present with elevated suicide risk.1,2 PTSD is
often comorbid with major depressive disorder,2 which further
increases the risk of suicide in patients with PTSD.1 The factors
underlying suicidal behavior in PTSD remain poorly understood.1 There are limited data that specifically address suicide
risk in the context of evidence-based treatments for PTSD, and
studies using evidence-based therapies such as prolonged exposure report a significant reduction in suicidal ideation among
only approximately 50% of patients.3
In addition to the core symptoms of nightmares and insomnia,2 there is also an increased prevalence of obstructive sleep
apnea (OSA) in PTSD.4 There is a paucity of studies of OSA and
Journal of Clinical Sleep Medicine, Vol. 14, No. 3
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Table 1—Demographic and clinical characteristics of study patients with PTSD (n = 40).
Age, years, mean ± SD (median; range)
Sex
BMI, kg/m2, mean ± SD (range)
Race
PCL-5 score, mean ± SD (range)
SI score, mean ± SD (range)
BDI-II score, mean ± SD (range)
PSQI global score, mean ± SD (range)
PSQI-A score, mean ± SD (range)
PSQI-A_NM score, mean ± SD (range)
ISI score, mean ± SD (range)
ESS score, mean ± SD (range)

44.60 ± 12.73 (43; 22–70)
38 female, 2 male
28.27 ± 6.02 (18.60–42.59)
39 White, 1 Native Canadian
40.40 ± 18.81 (4–74)
1.39 ± 1.05 (0–4)
27.85 ± 12.85 (4–53)
10.08 ± 4.79 (2–17)
6.61 ± 5.22 (0–17)
3.06 ± 3.07 (0–10)
13.36 ± 6.97 (0–25)
7.50 ± 4.44 (0–22)
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BDI-II = Beck Depression Index, second edition, BMI = body mass index, ESS = Epworth Sleepiness Scale, ISI = Insomnia Severity Index, PCL-5 = PTSD
Checklist for DSM-5, PSQI = Pittsburgh Sleep Quality Index, PSQI-A = PSQI Addendum for PTSD, PSQI-A_NM = modified version of PSQI-A including
only the nightmare items, PTSD = posttraumatic stress disorder, SD = standard deviation, SI = suicidal ideation.

Two recent epidemiologic studies5,6 have examined the relationship between sleep apnea and suicidal behavior. In a
study from the 2014 National Survey of Drug Use and Health
data (n = 41,086), there was a 2.9% prevalence of sleep apnea (sleep apnea cases identified based on response to a single
item where the participants were asked whether their doctor
had informed them that they had a diagnosis of sleep apnea
over the past 12 months); sleep apnea was associated with both
suicidal ideation (OR = 1.56, 95% CI 1.24–1.97) and suicide
planning (OR = 1.59, 95% CI 1.11–2.28), but not suicide attempts (OR = 1.19, 95% CI 0.65–2.18), after controlling for demographic factors, substance use, and depression.5 In a 10-year
prospective study of 74,543 cases of sleep apnea (diagnosed by
history and in-laboratory polysomnography or in-home overnight respiratory polygraphy) from the Swedish Patient Register, inpatient (generally representing more severe and complex
disease) but not outpatient sleep apnea was significantly associated with death from suicide in both men (hazard ratio
[HR] = 1.76, 95% CI 1.19–2.60) and women (HR = 4.33, 95%
CI 1.96–9.56) after controlling for comorbidities including cardiovascular disease, cancer, respiratory disorders, and diabetes.6 Psychiatric disorders such as depressive disease were not
controlled for in this study.6
To our knowledge, only one reported study has specifically
examined the relationship of sleep disturbance and sleepdisordered breathing (SDB) and suicide risk in patients with
PTSD7; a brief summary follows. The study included 153 female sexual assault survivors with PTSD; potential SDB and
sleep movement disorders were present in 80% of the participants (SDB and sleep movement disorders were diagnosed by
clinical practice parameters and research algorithms and not
polysomnography in this initial study). In comparison with the
patients with PTSD and no sleep disorders, there was significantly greater depression (Cohen d = 0.73–0.96, P < .01) and
greater suicidality (Cohen d = 0.57–0.78, P < .05) in the sleep
disorders group (which included both sleep movement disorders and SDB). In the subgroup with SDB only, there was a
medium effect size for depression (Cohen d = 0.73, P = .01) and
Journal of Clinical Sleep Medicine, Vol. 14, No. 3

suicidality (Cohen d = 0.57, P = .04). This study did not control
for the confounding effect of depression when examining the
relationship between SDB and suicidality.7
In the current study we have examined the relationship
between the severity of OSA measured with a home sleep
apnea test12 and suicidal ideation in patients with PTSD, after controlling for comorbid depression and other factors that
are known to contribute to suicidal ideation in PTSD. To our
knowledge, there are no previously reported studies that have
examined the relation between sleep apnea severity diagnosed
with sleep studies and suicidal ideation in PTSD. A better understanding of the relationship between sleep apnea and suicidal ideation in PTSD may provide further insight into factors
underlying suicide risk in PTSD and potentially identify specific clinical targets for the treatment of suicidal behavior in
patients with PTSD.
METHODS
The study was approved by the Office of Research Ethics, University of Western Ontario, London, Ontario, Canada. Forty
consecutive consenting civilians with PTSD secondary to
sexual trauma (all from the first author’s psychiatric practice)
(Table 1) completed a battery of psychiatric and sleep rating
scales and underwent one or more nights of unattended in-home
testing using the WatchPAT 200 (Itamar, Cesarea, Israel)12,13 for
the assessment of OSA and other sleep physiological measures,
as part of a larger study of sleep-related psychosomatic factors
in PTSD. All patients met the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)2 criteria for
moderate to severe PTSD with Clinician Administered PTSD
Scale for DSM-5 (CAPS-5)14 score of 55 or higher at the time
of initial consultation. The duration of PTSD symptoms in all
patients was more than 12 months. At the time of recruitment
for the WatchPAT 200 study (patients recruited from 0 to 24
months after their initial consultation for treatment of PTSD)
patients were in different stages of recovery from their PTSD
428
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Clinical Measures

symptoms. Exclusion criteria were as follows: (1) use of opioid
analgesics or benzodiazepines; otherwise patients remained on
all their regular medications (no patients were on medications
whose primary therapeutic effect was related to alpha adrenergic blockade such as phentolamine; however, patients remained
on antidepressants and prazosin for nightmares, which can
have varying degrees of peripheral alpha adrenergic receptor–
blocking effects); (2) history of excessive alcohol use or use of
recreational drugs including regular marijuana use; and (3) an
irregular sleep-wake schedule, or rotating shiftwork. None of
the patients had medical disorders that could interfere with peripheral arterial tonometry (such as peripheral vascular disease,
peripheral neuropathy, Raynaud disease, untreated cardiac arrhythmia, severe congestive heart failure, severe chronic obstructive pulmonary disease, and poorly controlled diabetes).

Measures of OSA
All patients underwent 1 or more nights of sleep recordings
using the WatchPAT 200; data from the first night of recording of more than 240 minutes sleep duration was used for
this study. The following indices of sleep-related breathing
disorder were obtained:
1. The AHI which is an index of the number of apnea and
hypopnea events per hour of sleep.
2. The RDI which is an index of the number of apnea,
hypopnea and respiratory effort related arousals
(RERA) per hour of sleep, and is the recommended
measurement of OSA severity for the WatchPAT200.20
The RDI was therefore used as the measure of
OSA in this study. The RDI score was further
divided into clinical severity categories21 of no OSA
(RDI < 5 events/h), mild OSA (RDI 5 to < 15 events/h),
moderate OSA (RDI 15 to < 30 events/h) and severe
OSA (RDI ≥ 30 events/h).
3. The ODI, which measures the number of times the
blood oxygen level drops ≥ 4% during sleep.20
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Home Sleep Apnea Test

Patients used the WatchPAT 200 device, which records four
channels, and is used unattended in the patient’s home. The
device is categorized as Level 3 by the American Academy of
Sleep Medicine.15 It uses peripheral arterial tonometry (PAT),
pulse oximetry, heart rate, and actigraphy to detect OSA,16
arousals from sleep,17 and sleep stages18,19 using the proprietary
zzzPAT software (Itamar, Cesarea, Israel).12 The PAT technology is a digital plethysmographic measurement method that records the pulsatile volume changes in the fingertip arteries that
reflect the relative state of the arterial vasomotor activity and
therefore indirectly the level of sympathetic activation.12,13 Peripheral arterial vasoconstriction, which mirrors sympathetic
activation, is shown as an attenuation in the amplitude of the
PAT signal.12 The WatchPAT 200 identifies the sleep/wake state
based on a unique algorithm of the actigraphic data and distinguishes between rapid eye movement (REM) and non-REM
sleep based on different autonomic functions.13 The WatchPAT
200 indirectly detects apnea and hypopnea events by identifying surges of sympathetic activation associated with the termination of these events. This information is further combined
with heart rate and pulse oximetry data that are analyzed by
the automatic algorithm of the system.13,16 Arousals from sleep
are associated with an increased sympathetic activation, and
peripheral vasoconstriction.13 Using a special automatic analysis algorithm, digital vasoconstrictions as measured by PAT,
combined with an increase in pulse rate, have been shown to
accurately reflect arousals from sleep.13,17
A systematic review and meta-analysis of studies assessing
correlation of sleep indices between PAT devices and Level
1 in-laboratory polysomnography (PSG) in adults revealed
a significant correlation between PAT devices and PSG for
apnea-hypopnea index (AHI) (r = .893, 95% CI 0.857–0.920,
P < .001), respiratory disturbance index (RDI) (r = .879, 95%
CI 0.849–0.904, P < .001), oxygen desaturation index (ODI)
(r = .942, 95% CI 0.894–0.969, P < .001),16 and arousals from
sleep (r = .87, P < .001).17 The sleep staging algorithm of the
PAT recording device has been validated,18 with overall agreement with PSG in detecting “light sleep” (PSG-scored stage N1
and N2 sleep) and “deep sleep” (PSG-scored stage N3 sleep) of
88.6% ± 5.9%, and overall agreement with PSG in detecting
stage R sleep (REM sleep) of 88.7% ± 5.5%.18
Journal of Clinical Sleep Medicine, Vol. 14, No. 3

The WatchPAT 200 defines an apnea as cessation of breathing
during sleep of a duration of 10 seconds or more; a hypopnea
as a reduction in breathing lasting 10 seconds or more followed
by oxygen desaturation of 3% or more and/or an arousal; and
a RERA as an obstructive event that does not meet the criteria
for an apnea or hypopnea but causes arousal from sleep.20
Data from the following self-report questionnaires, which
were generally completed within 1 week of completion of the
sleep study, were used.
Sleep Ratings
Pittsburgh Sleep Quality Index (PSQI): The PSQI is
designed to evaluate overall sleep quality and consists of 19
items that address 7 categories: subjective sleep quality, sleep
latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction.
A global score is derived by adding the 7 categories; a global
PSQI score higher than 5 has been shown to yield a diagnostic
sensitivity of 89.6% and specificity of 86.5% in distinguishing
good and poor sleepers.22 The global PSQI score was used in
our analysis.
Pittsburgh Sleep Quality Index Addendum for PTSD
(PSQI-A): The PSQI-A consists of seven items that focus on
the frequency of seven disruptive nocturnal symptoms including hot flashes (Item 1a), general nervousness (Item 1b), memories or nightmares of traumatic experience (Item 1c), severe
anxiety or panic not related to traumatic memories (Item 1d),
bad dreams not related to traumatic memories (Item 1e), episodes of terror or screaming during sleep without fully awakening (Item 1f) and episodes of “acting out” dreams such as
kicking, punching, running, or screaming (Item 1g). A global
PSQI-A score (range 0–21) of 4 has been shown to yield a
sensitivity of 94%, a specificity of 82%, and a positive predictive value of 93% for discriminating participants with versus
429
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Figure 1—Scatterplot of RDI versus SI scores in patients
with PTSD (n = 40).

Figure 2—Scatterplot of RDI versus SI scores among
the subset of patients with PTSD and RDI < 30 events/h
(n = 37).
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PTSD = posttraumatic stress disorder, RDI = respiratory disturbance
index, SI = suicidal ideation.

PTSD = posttraumatic stress disorder, RDI = respiratory disturbance
index, SI = suicidal ideation.

without PTSD.23 A modified version of the PSQI-A (PSQI-A_
NM) consisting of only the nightmare-related items (Items 1c,
1e, 1f, and 1g) (range 0–12) was considered to be an index of
PTSD-associated nightmares in this study.

following rating options: not at all (rating of 0), a little bit (rating of 1), moderately (rating of 2), quite a bit (rating of 3), and
severely (rating of 4). The SI scale that was derived from the
following 4 items of the BSI has been previously used 27 and
was created by deriving a mean score (possible range 0 to 4)
from responses to the following 4 items of the BSI: Item 9:
thoughts of ending your life; Item 35: feeling hopeless about
the future; Item 39: thoughts of death or dying; and Item 50:
feelings of worthlessness.

Insomnia Severity Index (ISI): A seven-item instrument
that assesses the nature, severity, and effect of sleep difficulties. The ISI measures the following dimensions of insomnia:
difficulty with falling asleep, staying asleep, and early morning awakening; satisfaction with current sleep pattern; whether
sleep problems are noticed by others; distress caused by sleep
difficulties; and interference of sleep difficulty with daytime
functioning. ISI scores (range 0–28) can be classified as absence of insomnia (0–7), subthreshold insomnia (8–14), moderate insomnia (15–21), and severe insomnia (22–28).24

PTSD Checklist for DSM-5 (PCL-5): The PCL-5 is a 20item questionnaire corresponding to the DSM-52 symptom criteria for PTSD. A total severity score (range 0–80) is obtained
by summing the scores from each of the 20 items. A PCL-5
cutoff score of 33 may be used to screen for PTSD.28

Epworth Sleepiness Scale (ESS): An eight-item instrument that provides the participant’s general level of daytime
sleepiness. The participants rate the chances that they would
doze off or fall asleep in eight different situations that are typically encountered in daily life. The ESS score is reported to
significantly distinguish nonclinical subjects from individuals
with OSA, idiopathic hypersomnia, and narcolepsy. A cutoff
score of 10 is used to identify clinically significant daytime
somnolence.25

Beck Depression Inventory – Second Edition (BDI-II):
is a 21-item self-rated instrument that is widely used to assess
the severity of depression in psychiatrically diagnosed adolescents and adults.29 The BDI-II measures severity of depression corresponding to the assessment of symptoms for major
depressive disorder listed in DSM-IV.30 Item 9 of the BDI-II
addresses suicidal ideation and was included in the final BDIII score. The following ranges of scores (overall range 0–63)
are used to classify depression severity: score of 0–13 denotes
minimal, score of 14–19 denotes mild, score of 20–28 denotes
moderate and a score of 29–63 denotes severe depression.29

Psychopathological Ratings
Assessment of SI: The items used to assess SI were extracted
from the Brief Symptom Inventory (BSI)26 which is a 53-item
inventory that measures 9 major psychiatric symptom dimensions including depression, interpersonal sensitivity, anxiety,
phobic anxiety, obsessive compulsiveness, paranoid ideation,
somatization, hostility, and psychoticism. Patients are asked to
rate how much they were bothered by each of the 53 items of
the BSI over the past week by using a 5-point scale with the
Journal of Clinical Sleep Medicine, Vol. 14, No. 3

Statistical Analysis

All statistical analyses were carried out using SPSS version
24.31 Scatterplots (Figure 1 and Figure 2) were obtained to
examine the overall relationships between RDI and SI scores.
Analysis of variance (ANOVA) was used to examine the differences in mean SI scores between the different clinical 21
430
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Figure 3—Means plot of RDI severity categories versus
mean SI scores.

Table 2—Correlation of SI scores with clinical and patientrated measures.
Demographic Factors
Age
BMI
OSA Indices
AHI
RDI
ODI
Sleep Questionnaire Measures
PSQI global score
PSQI-A_NM
ISI
ESS
Psychopathological Ratings
PCL-5
BDI-II
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RDI severity: 1 = < 5 events/h, 2 = 5 to < 15 events/h, 3 = 15 to < 30 events/h,
4 = ≥ 30 events/h. ANOVA = analysis of variance, RDI = respiratory
disturbance index, SI = suicidal ideation.

P

−.047
.011

.775
.949

.694
.757
.633

< .001
< .001
< .001

.082
.582
.248
.251

.614
< .001
.128
.119

.589
.752

< .001
< .001

BDI-II = Beck Depression Index, second edition, BMI = body mass
index, ESS = Epworth Sleepiness Scale, ISI = Insomnia Severity Index,
ODI = oxygen desaturation index, OSA = obstructive sleep apnea, PCL5 = PTSD Checklist for DSM-5, PSQI = Pittsburgh Sleep Quality Index,
PSQI-A = PSQI Addendum for PTSD, PSQI-A_NM = modified version of
PSQI-A including only the nightmare items, PTSD = posttraumatic stress
disorder, RDI = respiratory disturbance index, SI = suicidal ideation.

RDI severity categories of no OSA (RDI < 5 events/h),
mild OSA (RDI 5 to < 15 events/h), moderate OSA (RDI
15 to < 30 events/h) and severe OSA (RDI ≥ 30 events/h)
(Figure 3). Pearson product-moment correlations were carried out to examine the relation between SI and (1) clinical
factors including indices of OSA severity (AHI, RDI, ODI)
and (2) patient-rated sleep and psychopathologic measures
(Table 2). Multiple regression analysis was carried out using
SI as the dependent variable and the RDI and other known
confounding factors in the relationship between OSA and SI
as independent variables using (1) the entire sample (n = 40)
(Table 3) and (2) the subset of patients with RDI < 30 events/h
(n = 37) (Table 4), who represented the subgroup with mild
to moderate OSA. For this study only variables that were significantly correlated with SI (ie, PCL-5,28 depression [BDIII]29 and PTSD-associated nightmares [PSQI-A_NM]23) were
used as independent variables in the multiple regression models (Table 2, Table 3, and Table 4). For this study the modified PTSD-A_NM (which only included the items related to
nightmares and disturbing dreams) instead of the PTSD-A 23
was used in all the regression analyses. Finally, because depression is known to be associated with both SI and OSA,4
the possible mediating role of depression in the relationship
between OSA and SI was further assessed in (1) the entire
sample and (2) the subset excluding severe OSA representing
patients with RDI < 30 events/h, using the analysis proposed
by Baron and Kenny.32

specifically considered. The relationship between the RDI and
SI was essentially unchanged when the females alone (n = 38)
were considered. Figure 1 is a scatterplot of the RDI severity
versus SI (Pearson r = .757, P < .001; among females alone
Pearson r = .718, P < .001). Figure 2 is a scatterplot of RDI
severity versus SI in the subset of patients without severe OSA
(RDI < 30 events/h) (Pearson r = .511, P = .001; among females alone Pearson r = .516, P = .001). The frequency of RDI
severity (as per the standard clinical criteria for categorizing
severity21 of OSA) in the study sample was as follows: 15%
(n = 6) had no OSA (RDI < 5 events/h); 60% (n = 24) had mild
OSA (RDI 5 to < 15 events/h); 17.5% (n = 7) had moderate
OSA (RDI 15 to < 30 events/h); and 7.5% (n = 3) had severe
OSA (RDI ≥ 30 events/h). Therefore 85% of our patients with
PTSD had some degree of OSA (ie, RDI ≥ 5 events/h), with
most (60%) having mild OSA. Figure 3 plots the clinical RDI
severity categories and the mean SI scores for each RDI severity category, and indicates a direct and significant relationship
(P < .001 by ANOVA) between the clinical categories of OSA
severity and SI.
Table 2 summarizes the correlations between SI and (1)
demographic factors, (2) indices of OSA, (3) and patient selfratings of sleep and psychopathological factors that have been
associated with increased suicide risk in PTSD such as depression2 (measured with the BDI-II29), a PTSD diagnosis33 (PTSD
severity measured with PCL-528), severity of insomnia8–10
(measured with the ISI24), and nightmares8–10 (measured with
PSQI-A_NM23), in addition to a global index of sleep disturbance (measured with the PSQI22 global score) and sleepiness

R ES U LT S
The demographic characteristics of the patients with PTSD
(n = 40) in the study are summarized in Table 1. The median
age of (1) the entire sample and (2) females only (n = 38) was 43
years (Table 1); the menopausal status of the patients was not
Journal of Clinical Sleep Medicine, Vol. 14, No. 3

Correlation with SI
Pearson r
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Table 3—Results of multiple regression analysis (involving entire sample, n = 40) with SI scores as dependent variable.*
Independent
Variable
RDI***
BDI-II
PSQI-A_NM
PCL-5

Unstandardized
Regression
Coefficient (B)
.051
.040
.024
−.002

Standard Error
of B
.012
.012
.046
.008

Standardized
Regression
Coefficient (β)
.480
.469
.068
−.035

t
4.167
3.375
0.516
−0.240

P
< .001
.002
.610
.812

Collinearity Statistics**
Tolerance VIF
0.606
1.649
0.416
2.402
0.468
2.137
0.388
2.577

Asterisks indicate: * = model significant: F4,31 = 23.314, P < .0001, adjusted R 2 = 0.718 which explains 71.8% of the variance in SI scores; ** = tests to
see if the data met the assumption of collinearity indicated that multicollinearity was not a concern (Tolerance > 0.10 and VIF < 10); *** = when RDI was
replaced with the ODI, only ODI (β = .331, t = 2.737, P = .010) and BDI-II (β = .559, t = 3.687, P = .001) were significant predictors of SI, model significant at
F4,31 = 16.975, P < .001, adjusted R 2 = 0.646. BDI-II = Beck Depression Index, second edition, ODI = oxygen desaturation index, PCL-5 = PTSD Checklist for
DSM-5, PSQI-A_NM = modified version of Pittsburgh Sleep Quality Index Addendum for PTSD including only the nightmare items, PTSD = posttraumatic
stress disorder, RDI = respiratory disturbance index, SI = suicidal ideation, VIF = Variance Inflation Factor.
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Table 4—Results of multiple regression analysis (in subset of patients with RDI < 30 events/h, n = 37) with SI scores as
dependent variable.*
Independent
Variable
RDI***
BDI-II
PSQI-A_NM
PCL-5

Unstandardized
Regression
Coefficient (B)
.038
.042
.021
−.002

Standard Error
of B
.022
.012
.049
.008

Standardized
Regression
Coefficient (β)
.247
.603
.071
−.053

t
1.723
3.492
0.420
−0.291

P
.096
.002
.678
.773

Collinearity Statistics**
Tolerance VIF
0.746
1.340
0.514
1.945
0.545
1.835
0.459
2.180

Asterisks indicate: * = model significant: F4,28 = 9.285, P < .0001, adjusted R 2 = 0.509, which explains 50.9% of the variance in SI scores; ** = tests to see if
the data met the assumption of collinearity indicated that multicollinearity was not a concern (Tolerance > 0.10 and VIF < 10); *** = when RDI was replaced
with the ODI, only BDI-II (β = .656, t = 3.717, P = .001) remained a significant predictor of SI, and ODI (β = .121, t = 0.861, P = .397) was no longer a predictor;
model significant at F4,28 = 8.114, P < .001, adjusted R 2 = 0.471. BDI-II = Beck Depression Index, second edition, ODI = oxygen desaturation index, PCL5 = PTSD Checklist for DSM-5, PSQI-A_NM = modified version of Pittsburgh Sleep Quality Index Addendum for PTSD including only the nightmare items,
PTSD = posttraumatic stress disorder, RDI = respiratory disturbance index, SI = suicidal ideation, VIF = Variance Inflation Factor.

(Table 3). The results were similar when the RDI was substituted with the ODI in the multiple regression model (Table 3,
footnote). As expected, the RDI and ODI were significantly
correlated (Pearson r = .817, P < .0001).
As depression is associated with both OSA4 and SI, a separate analysis was carried out to further examine the possible
mediation32 of the relationship between OSA and SI by depression. A mediator variable is defined32 as one that accounts
for most or part of the relationship between the independent
variable (IV) (ie, RDI) and dependent variable (DV) (ie, SI).
The following three steps (as proposed by Baron and Kenny32)
were carried out for the mediation analysis: (1) regression of
the DV (SI) on IV (RDI) (standardized coefficient c = .757,
P < .001); (2) regression of the mediator (BDI-II) on IV (RDI)
(standardized coefficient a = .575, P < .001); and (3) regression
of the DV (SI) on both the mediator (BDI-II) (standardized
coefficient b = .473, P < .001) and IV (RDI) (standardized coefficient cʹ = .485, P < .001). As c and cʹ were both significant
we tested whether cʹ was significantly smaller than c using
the Sobel test,34,35 which revealed Z = 3.065, P = .006. The
results of the mediation analysis demonstrated that the relationship between the RDI and SI was partially mediated by
depression (BDI-II), when the entire study sample (n = 40)
was considered.

(measured with the ESS25). There was a 72.5% frequency (n = 29)
of moderate to severe depression (BDI-II ≥ 20) in the patients
with PTSD. Comparison of the BDI-II29 scores between the
RDI severity categories21 using ANOVA revealed that patients
with severe OSA (RDI > 30 events/h) (n = 3) had significantly
higher BDI-II scores (mean ± SD score: 46.67 ± 5.51) than patients with no OSA (RDI < 5 events/h) (n = 6) (mean ± SD
score: 14.83 ± 7.88) (P < .001) and mild OSA (RDI 5 to < 15
events/h) (n = 24) (mean ± SD score: 26.58 ± 11.81 (P = .020),
but not in comparison with the BDI-II scores in the moderate
OSA group (RDI 15 to < 30 events/h) (n = 7) (mean ± SD score:
35.29 ± 7.65) (P = .739).

Analysis Involving the Entire Sample (n = 40)

The RDI (Pearson r = .757, P < .001) and ODI (Pearson r = .633,
P < .001) were directly correlated to SI (Table 2). The results
of the multiple regression analysis involving the entire sample
(n = 40) (Table 3) revealed that RDI (standardized regression
coefficient or β = .480, t = 4.167, P < .001) remained a significant predictor of SI even after controlling for depression
(BDI-II) (β = .469, t = 3.375, P = .002) and other potential confounders (PCL-5 and PSQI-A_NM). Therefore, in addition to
the RDI, only the depression scores measured by the BDI-II
remained a significant predictor of SI in the regression model
Journal of Clinical Sleep Medicine, Vol. 14, No. 3
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Analysis Involving the Subset of Patients With RDI < 30
events/h (n = 37)

(60% had mild OSA), and the patients with PTSD as a group
reported mild insomnia (with a mean ± SD ISI24 score of
13.36 ± 6.97). These sleep characteristics are consistent with
previous findings in patients with PTSD among whom there is
a high prevalence of OSA,4 and who experience multiple sleep
complaints and tend to have predominantly OSA with insomnia36 rather than hypersomnia. These clinical characteristics
further support the representativeness of our study sample.
The most salient finding is the direct and graded ‘dose-response’ type relationship between clinically measured RDI and
suicidal ideation (Figure 1, Figure 2, and Figure 3). Multiple
regression analysis involving the entire study sample (n = 40)
(Table 3) using SI as the dependent variable and RDI, depression, PTSD severity, and PTSD-related nightmares as independent variables revealed that both OSA (β = .480, t = 4.167,
P < .001) and depression (β = .469, t = 3.375, P = .002) were
significant predictors of SI, with the model explaining 71.8%
of the variance in SI scores (Table 3). The RDI remained a
significant predictor of SI, independent of comorbid depression and other factors that have been associated with increased
suicide risk in PTSD. A separate mediation analysis32 showed
a significant (P = .006) partial mediating effect of depression
(BDI-II) in the relationship between RDI and SI. There was
also a significant (Pearson r = .633, P < .001) direct relationship
between the ODI and SI, which remained significant when RDI
was substituted with the ODI in the multiple regression model
where both ODI (β = .331, t = 2.737, P = .010) and depression
(BDI-II) (β = .559, t = 3.687, P = .001) remained significant predictors of SI (Table 3, footnote). These results suggest the possible roles of both depression and OSA-associated intermittent
hypoxemia in the relationship between RDI and SI in the entire
study sample, which included patients with severe OSA. However, the same multiple regression analysis involving the subset
of patients excluding severe OSA (RDI < 30 events/h) (n = 37)
(Table 4) revealed that depression (BDI-II) alone (β = .603,
t = 3.492, P = .002), and not RDI (β = .247, t = 1.723, P = .096)
remained the only significant predictor of SI in the multiple
regression model (Table 4). This was further confirmed by
the results of the mediation analysis, where depression alone
mediated the relationship between RDI and SI. These previously unreported finding in patients with PTSD suggest that
depression (measured by the BDI-II) was the most important
mediator in the relationship between OSA and SI, with OSArelated intermittent hypoxemia possibly further contributing to
this relationship only in patients with PTSD and severe OSA.
Patients with PTSD are more likely to experience both OSA4
and depression 2 and the comorbidity of OSA and depression
is likely an important mediating factor in the relationship between OSA and SI in patients with PTSD. Patients with PTSD
as a group are more likely to experience suicidal ideation33 and
it is possible that the oxidative stress associated with intermittent hypoxemia in OSA37 further unmasks the underlying
predisposition for suicidal ideation. Hypoxemia has also been
associated with decreased serotonin synthesis and increased
suicide rates,38 and this has been attributed to the effect of hypoxemia on tryptophan hydroxylase, the rate-limiting enzyme
in serotonin synthesis.38 Finally, increased PTSD severity is
typically associated with greater suicide risk and higher levels

The correlation between RDI and SI remained significant in
the subset of patients without severe OSA (RDI < 30 events/h)
(Pearson r = .511, P = .001) (Figure 2); however, the correlation of SI with ODI was no longer significant (Pearson r = .312,
P = .060) in this less severely affected group. Result of the
multiple regression analysis in this subset (Table 4) of patients
with less severe OSA revealed that the RDI (β = .247, t = 1.723,
P = .096) no longer remained a significant predictor of SI when
depression (BDI-II) and other potential confounders (PCL-5
and PSQI-A_NM) were entered into the regression model, and
only the depression scores (measured by BDI-II) remained a
significant predictor (β = .603, t = 3.492, P = .002) of SI in the
multiple regression model (Table 4). The results were similar
when the RDI was substituted with the ODI in the multiple regression model (Table 4, footnote).
A separate mediation analysis32 was carried out to examine
the possible mediation of the relationship between RDI and
SI by depression (BDI-II). The following three steps (as proposed by Baron and Kenny)32 were carried out for the mediation
analysis: (1) regression of the DV (SI) on IV (RDI) (standardized coefficient c = .511, P = .001); (2) regression of the mediator (BDI-II) on IV (RDI) (standardized coefficient a = .460,
P = .004); and (3) regression of the DV (SI) on both the mediator (BDI-II)(standardized coefficient b = .593, P < .001) and IV
(RDI) (standardized coefficient cʹ = 0.239, P = .077). As cʹ was
not significant, the results of the mediation analysis indicated
that in the subset of patients with RDI < 30 events/h, the relationship between RDI and SI was entirely mediated by depression (BDI-II).
D I SCUS S I O N
We examined the relationship between the severity of OSA
as measured by the RDI12,16 and SI in 40 civilian patients
with PTSD. There was a direct correlation between RDI and
SI (Pearson r = .757, P < .001) (Figure 1). The correlation remained significant when the subset of patients without severe
OSA (RDI < 30 events/h) (n = 37) was considered (Pearson
r = .511, P = .001) (Figure 2). To our knowledge, this is the first
reported study that has examined the relationship of clinically
measured OSA and SI in patients with PTSD.
The patients with PTSD, who all met DSM-52 criteria for
moderate to severe PTSD at the time of initial consultation,
were at different stages of recovery when they were recruited
for the study, and their mean ± standard deviation (SD) PCL-528
score of 40.40 ± 18.81 (Table 1) was consistent with a PTSD
diagnosis and suggestive of a wide range of PTSD severity.
The mean ± SD BDI-II29 score was 27.85 ± 12.85 (Table 1),
and 72.5% of the study sample had moderate to severe depression (BDI-II ≥ 20), which are both consistent with the fact that
depression is frequently comorbid with PTSD.2 The patients
with PTSD (Table 1) as a group were poor sleepers (as per the
mean ± SD global PSQI21 score of 10.08 ± 4.79), were not excessively sleepy (as per the mean ± SD ESS25 score of 7.50 ± 4.44)
even though 85.0% had some degree of OSA (AHI ≥ 5 events/h)
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of sympathetic activation.2 The direct correlation between
PTSD severity and SI was also present in our sample (Table 2).
The higher level of sympathetic activation can lead to a lower
respiratory arousal threshold, which can be associated with increased ventilatory instability and an increased RDI.39 This is
further consistent with our finding that most of our patients
with PTSD (60%) had mild OSA (RDI 5 to < 15 events/h), suggesting that the high level of sympathetic activation in patients
with more severe PTSD could have in part contributed to a low
arousal threshold and ventilatory instability39 and the modest
increase in RDI observed in most of the patients. Increased
sympathetic activation in PTSD may therefore be a mediating factor between SI and OSA severity in PTSD. SI in PTSD
tends to be associated with more severe PTSD, and therefore
SI, when associated with greater levels of sympathetic activation2 may in turn be associated with greater ventilatory instability.39 Our results suggest a possible bidirectional relationship
between OSA and SI in PTSD.
In conclusion, our previously unreported finding of a graded
“dose-response” type relationship between OSA severity and
SI suggests the possible role of several factors (such as depression and possibly intermittent hypoxemia and a low respiratory
arousal threshold secondary to the sympathetic activation in
PTSD in severe OSA) underlying a possibly bidirectional relationship between OSA severity and SI in PTSD. Some of the
limitations of this study include the small sample size, a high
predominance of female subjects, lack of data on the menstrual
status, and the fact that the subjects were not necessarily drug
free. Our findings from this cross-sectional study need to be
followed up with prospective studies that assess the relationship between changes in RDI and ODI (and other indices of
oxygen desaturation) to SI before and after OSA treatment.
Ideally these studies would comprise patients with PTSD who
are drug free and represent a wide range of OSA severity—especially severe OSA. Our findings highlight the importance of
comorbid OSA as one of the possible treatment targets in the
management of SI in PTSD. Our results suggest that factors
related to depression and central nervous system activation
and factors related to upper airway obstruction and associated
hypoxemia need to be taken into consideration when treating
comorbid OSA in patients with PTSD and SI.

OSA, obstructive sleep apnea
PAT, peripheral arterial tonometry
PCL, PTSD Checklist
PSG, polysomnography
PSQI, Pittsburgh Sleep Quality Index
PTSD, posttraumatic stress disorder
RDI, respiratory disturbance index
REM, rapid eye movement
RERA, respiratory effort related arousal
SD, standard deviation
SDB, sleep-disordered breathing
SI, suicidal ideation
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